UK Public Accounts Committee report highlights issues in cladding remediation

A report from the UK Committee of Public Accounts has raised concerns over delays and costs in cladding remediation across the country.

According to Light Science Technologies, the Injectaclad solution provided by its subsidiary Injecta Fire Barrier could offer a cost-effective, less disruptive method for cavity remediation.

The report, published on Friday 21 March 2025, found that work has yet to begin on half of the identified buildings.

It stated that the initial estimate of £600 million for 450 buildings has increased to a projected £12.6 billion to £22.4 billion for 9,000 to 12,000 medium and high-rise buildings.

It also highlighted a shortage of skilled workers and an increase in the expected scope of work.

Injectaclad solution positioned as alternative to façade removal

Injectaclad is installed within the internal cavity of a building, removing the need to dismantle brick or rendered façades.

Light Science Technologies stated that project quotes for Injectaclad are typically three times lower than conventional façade removal methods.

It added that the system enables reduced disruption for residents and shorter project durations.

It is designed to support lower risk mitigation under PAS 9980 guidance for fire risk assessments of external wall construction.

Injecta Fire Barrier activity since acquisition

Since its acquisition in November 2023, Injecta Fire Barrier has received orders totalling £2.7 million and has completed work on 11 buildings.

It currently has a quoted pipeline of active projects valued at £16.5 million.

Light Science Technologies expects this pipeline to convert at a faster rate following the Building Safety Regulator’s commitment to clear a backlog of 122 Gateway 2 projects by the end of April 2025.

CEO comments on cladding remediation and Injectaclad’s role

Simon Deacon, Chief Executive Officer of Light Science Technologies, commented on the Public Accounts Committee’s findings and the role Injectaclad could play in improving remediation progress.

Deacon said: “This report clearly highlights the slow progress on vital remediation work in the UK.

“In addition to that, public consensus is that the 2029 target for completing works is an unacceptably long time for this work to go undone.

“A stark reminder of this danger came only last August with the Dagenham fire.

“We have a compelling solution that meets new safety standards, saves money, is far faster to implement, causes significantly less disruption, and is quick to scale.

“Wider adoption of Injectaclad ultimately means that homes and places of work will be safer; both at a faster rate and with less financial burden.”

UK remediation delays highlight demand for less disruptive cavity fire safety solutions: Summary

The UK Committee of Public Accounts published a report on 21 March 2025 addressing delays in cladding remediation.

Light Science Technologies stated that its Injectaclad product offers a cost-effective solution.

The report said half of identified buildings have not had work started.

Projected costs have risen from £600 million to between £12.6 billion and £22.4 billion.

Injectaclad is installed within wall cavities, avoiding façade removal.

The system aligns with PAS 9980 guidance.

Since November 2023, Injecta Fire Barrier has completed work on 11 buildings.

It has taken £2.7 million in orders and built a quoted project pipeline worth £16.5 million.

The Building Safety Regulator aims to clear a backlog of 122 Gateway 2 projects by April 2025.

Simon Deacon, CEO of Light Science Technologies, said the Injectaclad solution reduces disruption and cost.